Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Details)

v3.24.3
Intangible Assets (Details) - USD ($)
3 Months Ended 15 Months Ended
Feb. 25, 2024
Sep. 19, 2022
Aug. 23, 2021
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Finite-Lived Intangible Assets [Line Items]            
Amortization of Intangible Assets       $ 5,000 $ 5,000 $ 5,000
Stock Purchase Agreement | RubrYc Therapeutics            
Finite-Lived Intangible Assets [Line Items]            
Investment in RubrYc     $ 7,500,000      
Asset Purchase Agreement | RubrYc Therapeutics            
Finite-Lived Intangible Assets [Line Items]            
Investment in RubrYc   $ 1,342,000        
PD-1 Asset Purchase Agreement | Otsuka Pharmaceutical | Intellectual Property            
Finite-Lived Intangible Assets [Line Items]            
Proceeds from sale of intellectual property $ 1,000,000.0          
Potential contingent payments related to sale of intellectual property $ 52,500,000